POSC350 Health Utility Values in the STEP 1–4 Trials of Semaglutide 2.4 MG in Obesity

Autor: Meincke, H, Bjorner, JB, Holst-Hansen, T, Grand, TS
Zdroj: In Value in Health January 2022 25(1) Supplement:S240-S240
Databáze: ScienceDirect